Fig. 5From: Prognostic value of cross-omics screening for kidney clear cell renal cancer survivalStage specific methylation changes. Higher methylation levels (shown in red) are observed in stage III and stage IV patients, while lower methylation levels (in green) are observed in stage I and stage II patients. “cgX” denotes the identifier of the plotted methylation probeBack to article page